Prognostic Awareness and Patient-Physician Communication in Malignant Glioma

NCT02023346 | Completed

• 1 other identifier: 13-253
• Study Type: observational
• Target: 95
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to learn more about the understanding patients with brain tumors have of their disease and their communication with their physician. Ultimately, we hope to use these findings to improve communication between patients and their doctors.

Conditions

Malignant Glioma

Keywords

Patient-Physician Communication; Brain cancer; 13-253

Outcome Measures

Primary Outcomes (1)

• measure prognostic awareness

  Prognostic awareness (PA) will be measured using the Chochinov Prognostic Awareness Scale. This scale classifies patients into three categories of awareness: full, limited, or no awareness.

  2 years

Study Arms (1)

Malignant Glioma patients

This is a cross-sectional study of patients with MG who are admitted to the inpatient Neurology service at MSKCC. We anticipate that participants will be accrued over approximately 18-24 months. All patients with MG admitted to Neurology, will be screened for eligibility and willingness to participate in the study.

Behavioral: surveys and cognitive tests

Interventions

surveys and cognitive tests BEHAVIORAL

Malignant Glioma patients

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Participants will be recruited from the inpatient Neurology service. Caregivers will be recruited from either the inpatient Neurology service (if they are physically present at the hospital at the time of the patient's consent to participate) or via telephone communication (if not physically present at the time of patient consent).

You may qualify if:

• Age greater than or equal to 18
• Diagnosis of any WHO grade III or IV glioma
• Admitted to the inpatient Neurology service
• Has had at least one outpatient visit with a neuro-oncologist at MSKCC Fluent in English
• Age greater than or equal to 18
• Identified by the patient as a relative, friend, or partner with whom he or she has a significant relationship and who provides him or her physical or emotional assistance.
• The patient has himself or herself agreed to participate in this study

You may not qualify if:

• A patient will be excluded if the Glasgow Coma Scale is less than 15. The patient must be oriented to self, age, place, and year, and month.
• Aphasia precluding comprehension and verbalization of consent to participate
• Patients who cannot verbally demonstrate their understanding of the risks, benefits, and alternatives to participating in the study. This evaluation will take place for otherwise eligible and willing participants, and it will be performed by the NP or MD clinician who is obtaining informed consent and will be documented in the medical record.
• No eligible caregivers who can complete the brief assessment in person or via telephone will be excluded

Sponsors & Collaborators

• Memorial Sloan Kettering Cancer Center: lead

Study Sites (1)

Memoral Sloan Kettering Cancer Center

New York, New York, 10065, United States

Location

Related Links

• Memorial Sloan Kettering Cancer Center

MeSH Terms

Conditions

Glioma; Brain Neoplasms

Interventions

Surveys and Questionnaires; Neuropsychological Tests

Condition Hierarchy (Ancestors)

Neoplasms, Neuroepithelial; Neuroectodermal Tumors; Neoplasms, Germ Cell and Embryonal; Neoplasms by Histologic Type; Neoplasms; Neoplasms, Glandular and Epithelial; Neoplasms, Nerve Tissue; Central Nervous System Neoplasms; Nervous System Neoplasms; Neoplasms by Site; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health; Psychological Tests; Behavioral Disciplines and Activities

Study Officials

• Eli Diamond, MD

  Memorial Sloan Kettering Cancer Center

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 23, 2013
• First Posted: December 30, 2013
• Study Start: December 1, 2013
• Primary Completion: October 30, 2018
• Study Completion: October 30, 2018
• Last Updated: November 1, 2018

Record last verified: 2018-10

Locations

US (1)